Hannes Neuwirt

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Topics

Peritoneal Dialysis

Prognostic Factors

Ejection Fraction

Circulating Tumor

Top Venues

Journal of clinical medicine

European journal of immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Lukas Lanser, Michaela Plaikner, Josia Fauser, Verena Petzer, Sara Denicolò, David Haschka, Hannes Neuwirt, Kiril Stefanow, Michael Rudnicki, Christian Kremser, Benjamin Henninger, Guenter Weiss
Tissue Iron Distribution in Anemic Patients with End-Stage Kidney Disease: Results of a Pilot Study. Journal of clinical medicine 13 (12) (2024)
Lukas Lanser, Michaela Plaikner, Josia Fauser, Verena Petzer, Sara Denicolò, David Haschka, Hannes Neuwirt, Kiril Stefanow, Michael Rudnicki, Christian Kremser, Benjamin Henninger, Guenter Weiss
Tissue Iron Distribution in Anemic Patients with End-Stage Kidney Disease: Results of a Pilot Study. Journal of clinical medicine 13 (12) (2024)
Mona Kafka, Rebecca Gruber, Hannes Neuwirt, Michael Ladurner, Iris E Eder
Long-Term Treatment with Simvastatin Leads to Reduced Migration Capacity of Prostate Cancer Cells. Biomedicines 11 (1) (2022)
Mona Kafka, Rebecca Gruber, Hannes Neuwirt, Michael Ladurner, Iris E Eder
Long-Term Treatment with Simvastatin Leads to Reduced Migration Capacity of Prostate Cancer Cells. Biomedicines 11 (1) (2022)
Michael Ladurner, Manuel Wieser, Andrea Eigentler, Martin Seewald, Gabriele Dobler, Hannes Neuwirt, Mona Kafka, Isabel Heidegger, Wolfgang Horninger, Jasmin Bektic, Helmut Klocker, Peter Obrist, Iris E Eder
Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer. Biomedicines 9 (8) (2021)
Hannes Neuwirt, Irmgard Leitner-Lechner, Julia Kerschbaum, Michael Ertl, Florian Pöggsteiner, Nicolas Pölt, Julius Mätzler, Hannelore Sprenger-Mähr, Michael Rudnicki, Peter Schratzberger, Iris E Eder, Gert Mayer
Efficacy and Safety of Belatacept Treatment in Renal Allograft Recipients at High Cardiovascular Risk-A Single Center Experience. Journal of clinical medicine 8 (8) (2019)
Beatrix Loeschenberger, Lea Niess, Reinhard Würzner, Hubert Schwelberger, Iris E Eder, Martin Puhr, Julia Guenther, Jakob Troppmair, Michael Rudnicki, Hannes Neuwirt
Calcineurin inhibitor-induced complement system activation via ERK1/2 signalling is inhibited by SOCS-3 in human renal tubule cells. European journal of immunology 48 (2) (2017)